基于CT的身体成分测量与系统性疾病:利用人工智能工具在逾10万患者中进行的群体水平分析
本回顾性研究纳入140,606例成人腹部CT,应用13种全自动AI身体成分工具测量肝脏、脾脏、肾脏体积与衰减、椎体骨小梁衰减、骨骼肌面积与衰减及腹部脂肪面积与衰减。在118,141例无或仅一种系统性疾病的患者中,年龄、性别及癌症、心血管疾病、糖尿病、肝硬化与多项身体成分测量相关(所有模型p<.001,R²=0.03-0.43)。作者认为这些关联对建立AI身体成分工具的参考范围至关重要。
要点
- 年龄可预测全部13项AI身体成分测量,性别预测12项,糖尿病预测13项。
- 癌症预测9项、心血管疾病预测11项、肝硬化预测12项身体成分测量(均p<.05)。
- 各模型拟合度差异较大,R²范围为0.03至0.43。
核心结论
- 年龄、性别及常见系统性疾病的存在是AI衍生CT身体成分测量的预测因素。
研究设计与样本
- 回顾性研究,纳入2000年1月1日至2021年2月28日在一家学术机构接受腹部CT的140,606例成人患者(67,613例男性、72,993例女性,平均年龄53.1±17.6岁),不限制患者场所、临床指征或静脉造影剂使用;对每例患者首次可用的腹部CT应用13种全自动AI身体成分工具;通过电子健康记录ICD-10编码识别癌症、心血管疾病、糖尿病和肝硬化;64,789例(46.1%)至少有一种系统性疾病;对118,141例(84.0%)无或仅一种系统性疾病的患者行多元线性回归,效应量用非标准化回归系数B表示。
诊断标准与关键数值
- 13种AI工具量化肝脏、脾脏和肾脏体积与衰减、椎体骨小梁衰减、骨骼肌面积与衰减以及腹部脂肪面积与衰减;以电子健康记录ICD-10编码定义癌症、心血管疾病、糖尿病和肝硬化;多元线性回归以年龄、性别和系统性疾病为预测因素,对全部13项身体成分测量总体显著(均p<.001),模型拟合度R²=0.03-0.43;年龄预测全部13项,性别预测12项,癌症预测9项,心血管疾病预测11项,糖尿病预测13项,肝硬化预测12项(均p<.05)。
临床应用与阅片要点
- 作者指出,理解所识别的与常见系统性疾病的关联,对于在CT-based AI身体成分工具走向临床使用时建立规范性参考范围至关重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. CT-based abdominal body composition measures have shown associations with important health outcomes. Advances in artificial intelligence (AI) now allow deployment of tools that measure body composition in large patient populations. OBJECTIVE. The purpose of this study was to assess associations of age, sex, and common systemic diseases with CT-based body composition measurements derived using a panel of fully automated AI tools in a population-level adult patient sample. METHODS. This retrospective study included 140,606 adult patients (67,613 men and 72,993 women; mean age, 53.1 ± 17.6 [SD] years) who underwent abdominal CT at a single academic institution between January 1, 2000, and February 28, 2021. CT examinations were not restricted on the basis of patient setting, clinical indication, or IV contrast media use. Thirteen fully automated AI body composition tools quantifying liver, spleen, and kidney volume and attenuation; vertebral trabecular attenuation; skeletal muscle area and attenuation; and abdominal fat area and attenuation were applied to each patient's first available abdominal CT examination. EHR review was performed to identify common systemic diseases, including cancer, cardiovascular disease (CVD), diabetes mellitus (DM), and cirrhosis, on the basis of relevant ICD-10 codes; 64,789 patients (46.1%) had at least one systemic disease diagnosed. Multiple linear regression models were performed for the 118,141 patients (84.0%) with no systemic disease or a single systemic disease, to assess age, sex, and the presence of systemic disease as predictors of body composition measures; effect sizes were characterized using the unstandardized regression coefficient B. RESULTS. Multiple linear regression models using age, sex, and systemic disease as predictors were overall significant for all 13 body composition measures (all p < .001) with variable goodness of fit (R2 = 0.03-0.43 across models). In the models, age was predictive of all 13 body composition measures; sex, 12 measures; cancer, nine measures; CVD, 11 measures; DM, 13 measures; and cirrhosis, 12 measures (all p < .05). CONCLUSION. Age, sex, and the presence of common systemic diseases were predictors of AI-derived CT-based body composition measures. CLINICAL IMPACT. An understanding of the identified associations with common systemic diseases will be critical for establishing normative reference ranges as CT-based AI body composition tools are developed for clinical use.
引用
- Pooler BD, Garrett JW, Lee MH, et al. CT-Based Body Composition Measures and Systemic Disease: A Population-Level Analysis Using Artificial Intelligence Tools in Over 100,000 Patients. AJR Am J Roentgenol. 2025. PMID: 39772583. doi:10.2214/AJR.24.32216
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。